ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.650
-0.180 (-9.84%)
At close: Sep 23, 2026, 4:00 PM EDT
1.660
+0.010 (0.61%)
Pre-market: Sep 24, 2026, 5:51 AM EDT
ProKidney Employees
ProKidney had 231 employees as of December 31, 2025. The number of employees increased by 27 or 13.24% compared to the previous year.
Employees
231
Change (1Y)
27
Growth (1Y)
13.24%
Revenue / Employee
$3,541
Profits / Employee
-$364,325
Market Cap
498.83M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 231 | 27 | 13.24% |
| Dec 31, 2024 | 204 | 41 | 25.15% |
| Dec 31, 2023 | 163 | 76 | 87.36% |
| Dec 31, 2022 | 87 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| REGENXBIO | 371 |
| Arvinas | 246 |
| Capricor Therapeutics | 231 |
| Allogene Therapeutics | 152 |
| Scribe Therapeutics | 82 |
| Assembly Biosciences | 73 |
| AgomAb Therapeutics NV | 62 |
PROK News
- 27 days ago - 20 stocks likely to lose money even if the bull market continues - Market Watch
- 6 weeks ago - ProKidney reports Q2 EPS (15c), consensus (14c) - TheFly
- 6 weeks ago - ProKidney Quarterly report: Q2 2026 - Filings
- 6 weeks ago - ProKidney Earnings release: Q2 2026 - Filings
- 3 months ago - ProKidney Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 3 months ago - ProKidney appoints Kenneth Locke as chief technical officer - TheFly
- 3 months ago - ProKidney Appoints Kenneth Locke as Chief Technical Officer - GlobeNewsWire
- 3 months ago - ProKidney Transcript: AGM 2026 - Transcripts